Ischemic Preconditioning and Intermittent Clamping Increase the Tolerance of Fatty Liver to Hepatic Ischemia-Reperfusion Injury in the Rat

Transplantation Proceedings

Volumn 39, Issue 10, 2007, Pages 3010-3014

  Saidi, R F ^a   Chang, J ^a   Brooks, S ^a   Nalbantoglu, I ^b   Adsay, V ^c   Jacobs, M J ^a  

^a PROVIDENCE HOSPITAL   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; EOSIN; HEMATOXYLIN; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DAMAGE; CONTROLLED STUDY; FATTY LIVER; ISCHEMIC PRECONDITIONING; LIVER CELL DAMAGE; LIVER ISCHEMIA; LIVER SURGERY; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; ZUCKER RAT;

ANESTHESIA, GENERAL; ANIMALS; FATTY LIVER; ISCHEMIC PRECONDITIONING; LIVER; LIVER CIRCULATION; MALE; RATS; RATS, ZUCKER; REPERFUSION INJURY;

EID: 37049006250     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.09.044     Document Type: Article

References (23)

1. Ploeg R.J., D'Alessandro A.M., and Knechtle S.J. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation 55 (1993) 807
2. Centers for Disease Control and Prevention. Overweight and obesity. http://www.cdc.gov/nccdphp/dnpa/obesity/ Accessed December 13, 2006
3. Lee C.T., Dunn R.L., Chen B.T., et al. Impact of body mass index on radical cystectomy. J Urol 172 (2004) 1281
4. Tsukada K., Miyazaki T., Kato H., et al. Body fat accumulation and postoperative complications after abdominal surgery. Am Surg 70 (2004) 347
5. Burke A., and Lucey M.R. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant 4 (2004) 686
6. Baldwin D., Chandrashekhar Y., McFalls E., et al. Ischemic preconditioning prior to aortic cross-clamping protects high energy phosphate levels, glucose uptake, and myocyte contractility. J Surg Res 105 (2002) 153
7. Murry C.E., Richard V.J., Reimer K.A., et al. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66 (1990) 913
8. Cavalieri B., Perrelli M.G., Aragno M., et al. Ischemic preconditioning attenuates the oxidant-dependent mechanisms of reperfusion cell damage and death in rat liver. Liver Transpl 8 (2002) 990
9. Koti R.S., Yang W., Dashwood M.R., et al. Effect of ischemic preconditioning on hepatic microcirculation and function in a rat model of ischemia reperfusion injury. Liver Transpl 8 (2002) 1182
10. Serafin A., Rosello-Catafau J., Prats N., et al. Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 39 (2004) 688
11. Fernandez L., Carrasco-Chaumel E., Serafin A., et al. Is ischemic preconditioning a useful strategy in steatotic liver transplantation?. Am J Transplant 4 (2004) 888
12. Clavien P.A., Yadav S., Sindram D., et al. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 232 (2000) 155
13. Hardy K.J., Tancheroen S., and Shulkes A. Comparison of continuous versus intermittent ischaemia-reperfusion during liver resection in an experimental model. Br J Surg 82 (1995) 833
14. Isozaki H., Adam R., Gigou M., et al. Experimental study of the protective effect of intermittent hepatic pedicle clamping in the rat. Br J Surg 79 (1992) 310
15. Horiuchi T., Muraoka R., Tabo T., et al. Optimal cycles of hepatic ischemia and reperfusion for intermittent pedicle clamping during liver surgery. Arch Surg 130 (1995) 754
16. Peralta C., Closa D., Hotter G., et al. Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun 229 (1996) 264
17. Vollmar B., Glasz J., Leiderer R., et al. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am J Pathol 145 (1994) 1421
18. White B.D., and Martin R.J. Evidence for a central mechanism of obesity in the Zucker rat: role of neuropeptide Y and leptin. Proc Soc Exp Biol Med 214 (1997) 222
19. Amersi F., Farmer D.G., Shaw G.D., et al. P-selectin glycoprotein ligand-1 (rPSGL-Ig)-mediated blockade of CD62 selectin molecules protects rat steatotic liver grafts from ischemia/reperfusion injury. Am J Transplant 2 (2002) 600
20. Coito A.J., Buelow R., Shen X.D., et al. Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. Transplantation 74 (2002) 96
21. Marzi I., Takei Y., Rucker M., et al. Endothelin-1 is involved in hepatic sinusoidal vasoconstriction after ischemia and reperfusion. Transpl Int 7 (1994) S503
22. TColletti L.M., Kunkel S.L., Walz A., et al. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 23 (1996) 506
23. Shito M., Wakabayashi G., Ueda M., et al. Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation 63 (1997) 143